nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus
|
Yao, Xueting |
|
2019 |
136 |
C |
p. |
artikel |
2 |
A quality by design approach to develop topical creams via hot-melt extrusion technology
|
Mendonsa, Nicole S. |
|
2019 |
136 |
C |
p. |
artikel |
3 |
Corrigendum to “CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance” [Eur. J. Pharm. Sci. 131 (2019) 177–194]
|
Sonawane, Vinay R. |
|
2019 |
136 |
C |
p. |
artikel |
4 |
Cryo-milling using a spherical sugar: Contamination-free media milling technology
|
Uemoto, Yoshifumi |
|
2019 |
136 |
C |
p. |
artikel |
5 |
Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs
|
Eedara, Basanth Babu |
|
2019 |
136 |
C |
p. |
artikel |
6 |
Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles
|
Steiner, Verena |
|
2019 |
136 |
C |
p. |
artikel |
7 |
Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)
|
Guo, Yong |
|
2019 |
136 |
C |
p. |
artikel |
8 |
Development of highly water-dispersible complexes between coenzyme Q10 and protein hydrolysates
|
Inada, Asuka |
|
2019 |
136 |
C |
p. |
artikel |
9 |
Editorial Board
|
|
|
2019 |
136 |
C |
p. |
artikel |
10 |
Exploration of long-acting implant formulations of hepatitis B drug entecavir
|
Henry, Steven J. |
|
2019 |
136 |
C |
p. |
artikel |
11 |
Hartmut Derendorf's work on tissue distribution
|
Vozmediano, Valvanera |
|
2019 |
136 |
C |
p. |
artikel |
12 |
How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions
|
Pacult, Justyna |
|
2019 |
136 |
C |
p. |
artikel |
13 |
Immune network for viral hepatitis B: Topological representation
|
Asín-Prieto, Eduardo |
|
2019 |
136 |
C |
p. |
artikel |
14 |
Impact of phase separation morphology on release mechanism of amorphous solid dispersions
|
Han, Yi Rang |
|
2019 |
136 |
C |
p. |
artikel |
15 |
Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity
|
Qi, Xiaoyi |
|
2019 |
136 |
C |
p. |
artikel |
16 |
Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer
|
Salmanpour, Mohsen |
|
2019 |
136 |
C |
p. |
artikel |
17 |
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study
|
Viola, Angelo |
|
2019 |
136 |
C |
p. |
artikel |
18 |
PAT-based batch statistical process control of a manufacturing process for a pharmaceutical ointment
|
Bostijn, N. |
|
2019 |
136 |
C |
p. |
artikel |
19 |
Population pharmacokinetics and Monte Carlo simulations of sulbactam to optimize dosage regimens in patients with ventilator-associated pneumonia caused by Acinetobacter baumannii
|
Jaruratanasirikul, Sutep |
|
2019 |
136 |
C |
p. |
artikel |
20 |
Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitor
|
Gu, Yi |
|
2019 |
136 |
C |
p. |
artikel |
21 |
Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods
|
Hagan, Alice |
|
2019 |
136 |
C |
p. |
artikel |
22 |
Prediction of the skin permeability of topical drugs using in silico and in vitro models
|
Alonso, Cristina |
|
2019 |
136 |
C |
p. |
artikel |
23 |
Publisher's Note
|
|
|
2019 |
136 |
C |
p. |
artikel |
24 |
Single-dose escalation study of yogliptin in healthy Chinese volunteers
|
Gou, Zhong-ping |
|
2019 |
136 |
C |
p. |
artikel |
25 |
Solid self-microemulsifying drug delivery system of Sophoraflavanone G: Prescription optimization and pharmacokinetic evaluation
|
Yang, Zhixin |
|
2019 |
136 |
C |
p. |
artikel |
26 |
Stability of a novel Lidocaine, Adrenaline and Tetracaine sterile thermosensitive gel: A ready-to-use formulation
|
Zanon, Davide |
|
2019 |
136 |
C |
p. |
artikel |
27 |
Stabilizing excipients for engineered clopidogrel bisulfate procubosome derived in situ cubosomes for enhanced intestinal dissolution: Stability and bioavailability considerations
|
El-Laithy, Hanan M. |
|
2019 |
136 |
C |
p. |
artikel |
28 |
Systematic evaluation of the impact of solid-state polymorphism on the bioavailability of thalidomide
|
de Oliveira, Guilherme Henrique Onório |
|
2019 |
136 |
C |
p. |
artikel |
29 |
The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1
|
Pedron, Cibele Nicolaski |
|
2019 |
136 |
C |
p. |
artikel |
30 |
The inhibitory role of curcumin derivatives on AMPA receptor subunits and their effect on the gating biophysical properties
|
Qneibi, Mohammad |
|
2019 |
136 |
C |
p. |
artikel |
31 |
Thermoplastic polyurethane as matrix forming excipient using direct and ultrasound-assisted compression
|
Casas, Marta |
|
2019 |
136 |
C |
p. |
artikel |
32 |
Transdermal delivery of fluvastatin loaded nanoemulsion gel: Preparation, characterization and in vivo anti-osteoporosis activity
|
Kaur, Ramandeep |
|
2019 |
136 |
C |
p. |
artikel |
33 |
Use of prior knowledge and extrapolation in paediatric drug development: A case study with deferasirox
|
Borella, Elisa |
|
2019 |
136 |
C |
p. |
artikel |